{"disease":{"id":"to-define-an-easy-and-feasible-panel-which-may-be-routinely-applied-to-select-patients-for-immunotherapy-avoiding-more-complex-and-expensive-methods","name":"to define an easy and feasible panel which may be routinely applied to select patients for immunotherapy avoiding more complex and expensive methods"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03816657","title":"The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)","phase":"","overall_status":"UNKNOWN","enrollment_count":93,"lead_sponsor_name":"Fondazione Ricerca Traslazionale","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}